This site is intended for UK healthcare professionals only.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC 2022

IMAGE

Loading

The impact of CKD in diabetes.

16 Nov 2022
Heart and Kidney Clinic

There are over a million people with undiagnosed CKD in the UK. In 2009/10, CKD was attributed to an excess 7000 strokes, 12,000 MIs and cost the NHS an additional £1.45billion. Diagnosis requires both eGFR and ACR. Failure of checking for ACR can underestimate the prevalence and severity of CKD. Pro-active diagnosis of CKD can reduce unplanned admissions, cardiovascular disease and end stage renal failure.

  • - CKD is under-diagnosed. Diagnosis requires both eGFR and ACR
  • - CKD increases the risk of coronary disease, heart failure, heart valve disease, stroke and limb amputation.
  • - Albuminuria is an independent risk factor for cardiovascular morbidity, mortality and end-stage renal failure
  • - Failure to diagnose and code CKD significantly increases mortality risk
  • - Treatment of CKD improves outcomes
Speakers
Raj Thakkar, GP, Primary Care Cardiology Lead- Oxford AHSN, National Primary Care workstream co-lead - CPIP, NHS England

Sponsors

Diamond Sponsor

  • AstraZeneca

 

Platinum Sponsor

  • Abbott

 

Platinum Sponsor

  • Dexcom

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Viatris

 

Gold Sponsor

  • BI

 

Gold Sponsor

  • BI & Lilly Alliance

 

Gold Sponsor

  • Eli Lilly

 

Gold Sponsor

  • GlucoRX

 

Gold Sponsor

  • Insulet

 

Silver Sponsor

  • owen mumford

 

Silver Sponsor

  • Sanofi

 

Registration Sponsor

  • Viatris